Alpha-L-Iduronidase (IDUA) Genetic Mutation Analysis
Alpha-L-Iduronidase is a monomeric globular enzyme found in lysosomes of cells. It is involved in the degradation of complex sugars called glycosaminoglycans (mucopolysacchharides). Alpha-L-Iduronidase hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate, thereby resulting in lysosomal degradation of both glycosaminoglycans. This enzyme plays a vital role in cell growth, adhesion, development and structural support. Deficiency of this enzyme leads to progressive accumulation of unhydrolyzed glycosaminoglycans throughout the body, which in turn leads to pathogenicity and clinical symptoms.
Hurler syndrome is a rare autosomal recessive inherited disorder caused by mutation in IDUA gene located at 4p16.3 on chromosome 4, which affects gene production of Alpha-L-Iduronidase resulting in an accumulation of glycosaminoglycan heparan sulfate and dermatan sulfate in tissues. Patients with Hurler syndrome typically experience developmental abnormalities, learning and intellectual disabilities, and various types of organ dysfunction. Patients with early onset experience a severe course and CNS involvement, and are typically classified as Hurler syndrome. Patients with the milder end of the spectrum are termed as Scheie syndrome; patients with intermediate symptoms are termed as Hurler-Scheie syndrome.
Mutation analysis in IDUA gene is used for carrier screening in individuals with a family history of Hurler syndrome and diagnosis purposes in effected individuals.
- Confirm diagnosis of Hurler syndrome for individuals presenting with clinical findings suggestive of a lysosomal storage disorder
- Carrier testing for individuals with a family history of Hurler syndrome
- Prenatal diagnosis for families with known IDUA mutation
- Preimplantation genetic diagnosis (PGD) for at-risk pregnancies
Negative:
Negative for mutation analyzed (Mutation not detected). The presence of Hurler disease cannot be completely excluded. Rare polymorphisms exist and can lead to false negative or false positive results. Results should be interpreted within the context of previous laboratory testing, clinical presentation, and family history. Additional testing is recommended for discordant results / findings.
Positive:
A mutation was detected in the IDUA gene. Interpretive report includes mutation location, change in DNA sequence, and resulting amino acid change.
Negative for mutation analyzed (Mutation not detected)
Plasma, Lavender top (EDTA).
Stability
- Ambient: 7 days
- Refrigerated: 7 days
- Metab Brain Dis. 2013 Jun; 27(2):121-9. [PMID: 22527994].
- Orphanet J Rare Dis. 2008 Sep 16;3(24). [PMID: 18796143]
- J Pathol. 2012 Jan;226(2):241-54. [PMID: 21990005]
- Mol Genet Metab. 2013 Aug;109(4):377-81. [PMID: 23786846]
- Clin Chim Acta. 2010 Mar;411(5-6):345-50. [PMID: 19954743]